WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1992000735) ROPINIROLE AND DOMPERIDONE FOR USE IN THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF PARKINSON'S DISEASE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1992/000735    International Application No.:    PCT/GB1991/001121
Publication Date: 23.01.1992 International Filing Date: 08.07.1991
Chapter 2 Demand Filed:    17.01.1992    
IPC:
A61K 31/40 (2006.01), A61K 31/445 (2006.01)
Applicants: SMITH KLINE & FRENCH LABORATORIES LIMITED [GB/GB]; Mundells, Welwyn Garden City, Hertfordshire AL7 1EY (GB) (For All Designated States Except US).
DE MEY, Christian [BE/DE]; (DE) (For US Only).
SREE HARAN, Nadarajah [LK/GB]; (GB) (For US Only)
Inventors: DE MEY, Christian; (DE).
SREE HARAN, Nadarajah; (GB)
Agent: GIDDINGS, Peter, J.; Corporate Patents, SmithKline Beecham, Mundells, Welwyn Garden City, Hertfordshire AL7 1EY (GB)
Priority Data:
9015095.4 09.07.1990 GB
Title (EN) ROPINIROLE AND DOMPERIDONE FOR USE IN THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF PARKINSON'S DISEASE
(FR) ROPINIROLE ET DOMPERIDONE UTILISES DANS LA PREPARATION D'UN MEDICAMENT POUR LE TRAITEMENT DE LA MALADIE DE PARKINSON
Abstract: front page image
(EN)The present invention relates to the dopamine D2-receptor antagonist, domperidone and the D2-receptor agonist, ropinirole for use in the treatment of Parkinson's disease.
(FR)La présente invention se rapporte au dompéridone, l'antagoniste de récepteur-D2 de dopamine, et au ropinirole, l'agoniste de récepteur-D2, utilisés dans le traitement de la maladie de Parkinson.
Designated States: AU, CA, JP, KR, US.
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LU, NL, SE).
Publication Language: English (EN)
Filing Language: English (EN)